Similar companies
Did Bristol-Myers Squibb Beat Earnings?
Bristol-Myers Squibb (BMY) reported Q2 '26 revenue of $13B, up 5.7% year-over-year, with reported EPS of $2.04. That topped the $1.59 analyst estimate by 28.3% — an earnings beat.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Bristol-Myers Squibb’s job postings, web traffic, and employee business outlook. See the full BMY stock analysis or the earnings calendar for upcoming reports.
BMY Earnings Surprise History (EPS vs. Estimate)
| Quarter | Estimated EPS | Reported EPS | Surprise |
|---|---|---|---|
| Q2 '26 | $1.59 | $2.04 | Beat +28.3% |
| Q1 '26 | $1.42 | $1.58 | Beat +11.3% |
| Q4 '25 | $1.20 | $1.26 | Beat +5.0% |
| Q3 '25 | $1.52 | $1.63 | Beat +7.2% |
| Q2 '25 | $1.10 | $1.46 | Beat +32.7% |
| Q1 '25 | $1.50 | $1.80 | Beat +20.0% |
Bristol-Myers Squibb Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11.9B | 12.3B | 11.2B | 12.3B | 12.2B | 12.5B | 11.5B | 13B |
| Gross margin | 55.6% | 60.2% | 72.9% | 72.5% | 71.9% | 67.2% | 70.2% | 71.3% |
| Operating margin | 19.2% | 20.5% | 31.2% | 30.8% | 29.8% | 22.5% | 29.3% | 31.5% |
| Net income | 1.21B | 72M | 2.46B | 1.31B | 2.2B | 1.09B | 2.68B | 3.32B |
| Net margin | 10.2% | 0.6% | 21.9% | 10.7% | 18.0% | 8.7% | 23.3% | 25.6% |
| EPS | $1.80 | $1.67 | $1.80 | $1.46 | $1.63 | $1.26 | $1.58 | $2.04 |
Bristol-Myers Squibb Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Bristol-Myers Squibb’s quarterly revenue moved from $11.9B to $13B. Net margin expanded from 10.2% to 25.6%, against a 71.3% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. Bristol-Myers Squibb has beaten Wall Street EPS estimates in 8 of its last 8 reported quarters.
When Is Bristol-Myers Squibb’s Next Earnings Date?
Bristol-Myers Squibb reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the BMY earnings calendar.
Frequently Asked Questions: Bristol-Myers Squibb Earnings
Bristol-Myers Squibb's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Bristol-Myers Squibb reported Q2 '26 EPS of $2.04 on revenue of $13B (+5.7% YoY). Bristol-Myers Squibb beat estimates, reporting $2.04 vs. the $1.59 estimate.
Bristol-Myers Squibb reported Q2 '26 revenue of $13B, up 5.7% from the same quarter a year earlier.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the BMY AI Score.
